Pancreas Cancer: Update on Cancer Biology, Treatment, and Outcome


Pancreas Cancer: Update on Cancer Biology, Treatment, and Outcome Banner

Add to Calendar Pancreas Cancer: Update on Cancer Biology, Treatment, and Outcome 11/18/2022 7:00:00 AM 11/19/2022 1:15:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=36229 Description: The incidence of pancreascancer continues to rise, and related morbidity and mortality remain unacceptably high. Treatment approaches continue to evolve with better insights into disease pathogenesis and progression. This day and a half long, in-person symposium is a combined effort of MSK’s Hepatopancreatobiliary Disease Management Team (HPB DMT) and Center for Pancreatic Cancer Research (CPCR) andw... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Friday, November 18, 2022, 7:00 AM - Saturday, November 19, 2022, 1:15 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Diagnostic Radiology, Epidemiology, Gastroenterology, Gastrointestinal Oncology, General Surgery, Genetics, Immunotherapy, Internal Medicine, Interventional Radiology, Molecular Biology, Oncology and Hematology, Pathology, Radiation Oncology, Social Work, Solid Tumor Oncology

Overview

The incidence of pancreas cancer continues to rise, and related morbidity and mortality remain unacceptably high. Treatment approaches continue to evolve with better insights into disease pathogenesis and progression.

This day and a half long, in-person symposium is a combined effort of MSK’s Hepatopancreatobiliary Disease Management Team (HPB DMT) and Center for Pancreatic Cancer Research (CPCR) and will provide a comprehensive review of the epidemiology, genomic, and immunologic features of pancreatic adenocarcinoma and how advances in these areas are impacting current management.

The program will include an emphasis on contemporary management approaches in patients with resectable and unresectable disease, the respective roles of and outcomes of chemotherapy (adjuvant/neoadjuvant/palliative) and radiation therapy (standard/ablative), and a discussion of novel and emerging therapies, including immunotherapy, vaccines, and genomic-directed therapies. Didactic sessions will be supplemented with several case presentations with audience participation. We will also feature a presentation from one of our patients recently treated for pancreas cancer.

Who Should Attend*

This symposium is intended for medical and surgical oncologists, gastroenterologists, internal medicine specialists, pathologists, geneticists, pharmacists, supportive care staff, advanced practice practitioners, nurses, trainees, and other disciplines. MSK is pleased to extend a complimentary invitation to patients/caregivers who wish to attend this program (details below).

*This program will be held IN-PERSON only. Please note that all in-person attendees must be vaccinated against COVID-19. Additional details, including our current Health and Safety Protocols can be accessed on our Visiting Us page.

Networking Reception

Attendees of this program are invited to join the course faculty for a networking reception from 5:00-6:00 pm on Friday evening in the lobby of Zuckerman Research Center. Hors d'oeuvre and refreshments will be served.
Objectives
  1. Update the genetic and molecular hallmarks of pancreas cancer
  2. Outline current diagnostic approaches in patients with pancreas cancer
  3. Describe contemporary surgical strategies, including the role of vascular reconstruction
  4. Review contemporary non-surgical therapies in the adjuvant, neoadjuvant and palliative settings
  5. Define novel and emerging therapies

Registration

Registration Fees

  • Physicians (MDs, PhDs, and DOs): $400
  • Advanced Practice Providers: $350
  • Residents, Fellows, Nurses, and Other Healthcare Providers: $250
  • Patients: complimentary*
  • Industry Professionals: $700**

Course registration includes continental breakfast, lunch, and refreshment breaks. Please contact [email protected] at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

All in-person attendees must be vaccinated against COVID-19. Additional details, including our current Health and Safety Protocols can be accessed on our Visiting Us page.

Registration Discounts/Promotions

  • *Registration is required for all patients interested in attending on a complimentary basis. If you are a patient interested in attending, please email [email protected] to register for this program.
  • A registration discount is available for MSK Alumni and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
  • Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

**Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services are strictly prohibited at MSK CME activities.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending and contact MSK CME ([email protected]).


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM and ABS MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 12.00 Medical Knowledge MOC points in the American Board of Internal Medicine's Maintenance of Certification Assessment Recognition program; and
  • 12.00 Accredited CME and Self-Assessment MOC points in the American Board of Surgery’s Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit.